The two, apparently, most prominent fractions of T lymphocytes in MS lesions are the CD4+ TH1 and CD4+ TH17 populations expressing IFNγ and IL-17, respectively [59,60]. This evidence concerns the gene CD4 and myeloid sarcoma.